Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

Jonathan Martinelli; Marianna Fekete; Lorenzo Tei; Mauro Botta

doi:10.1039/c0cc05428c

Cleavable β-cyclodextrin nanocapsules incorporating Gd^III-chelates as bioresponsive MRI probes

Jonathan Martinelli, Marianna Fekete, Lorenzo Tei, Mauro Botta

Dipartimento di Scienze e Innovazione Tecnologica

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo Gd^III-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.

Lingua originale	Inglese
pagine (da-a)	3144-3146
Numero di pagine	3
Rivista	Chemical Communications
Volume	47
Numero di pubblicazione	11
DOI	https://doi.org/10.1039/c0cc05428c
Stato di pubblicazione	Pubblicato - 1 mar 2011

Accesso al documento

10.1039/c0cc05428c

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{b6853e1638614511a8f651a0ad676c79,

title = "Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes",

abstract = "Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo GdIII-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.",

author = "Jonathan Martinelli and Marianna Fekete and Lorenzo Tei and Mauro Botta",

year = "2011",

month = mar,

day = "1",

doi = "10.1039/c0cc05428c",

language = "English",

volume = "47",

pages = "3144--3146",

journal = "Chemical Communications",

issn = "1359-7345",

publisher = "Royal Society of Chemistry",

number = "11",

}

TY - JOUR

T1 - Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

AU - Martinelli, Jonathan

AU - Fekete, Marianna

AU - Tei, Lorenzo

AU - Botta, Mauro

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo GdIII-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.

AB - Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo GdIII-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.

UR - https://www.scopus.com/pages/publications/79952834866

U2 - 10.1039/c0cc05428c

DO - 10.1039/c0cc05428c

M3 - Article

SN - 1359-7345

VL - 47

SP - 3144

EP - 3146

JO - Chemical Communications

JF - Chemical Communications

IS - 11